SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-21-000282
Filing Date
2021-08-18
Accepted
2021-08-18 14:16:07
Documents
51
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgbp033121form10q.htm 10-Q 1305884
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9503
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9482
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4228
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4100
  Complete submission text file 0001607062-21-000282.txt   4477084

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rgbp-20210331.xml EX-101.INS 676745
7 XBRL SCHEMA FILE rgbp-20210331.xsd EX-101.SCH 69105
8 XBRL CALCULATION FILE rgbp-20210331_cal.xml EX-101.CAL 40296
9 XBRL DEFINITION FILE rgbp-20210331_def.xml EX-101.DEF 200167
10 XBRL LABEL FILE rgbp-20210331_lab.xml EX-101.LAB 324871
11 XBRL PRESENTATION FILE rgbp-20210331_pre.xml EX-101.PRE 247999
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 211186408
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences